Ipsen Completes Acquisition of Kartos Therapeutics, Adding Phase III Myelofibrosis Drug Candidate

Ipsen announced it has completed the acquisition of Kartos Therapeutics, a clinical-stage biopharmaceutical company adding late-stage MDM2 inhibitor navt...

August 24, 2026 | Monday | News
Johnson & Johnson Wins EU Approval for TECVAYLI Plus Daratumumab in Earlier-Line Multiple Myeloma

Johnson & Johnson announced that the European Commission (EC) has approved an indication extension for TECVAYLI®(teclistamab) in combination with...

August 24, 2026 | Monday | News
Alvotech and Lotus Pharmaceutical Partner to Commercialize Two Biosimilar Candidates in U.S. and Asia

Alvotech , a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced a str...

August 24, 2026 | Monday | News
SK pharmteco Opens Expanded Manufacturing Facilities at Swords Campus in Ireland

SK pharmteco recently hosted a formal ribbon-cutting ceremony to mark the official opening of two major facility expansions at its manufacturing campus i...

August 20, 2026 | Thursday | News
Bristol Myers Squibb Receives FDA Accelerated Approval for ZENBEXUS in Multiple Myeloma

-Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved ZENBEXUS™ (iberdomide) in combination with darat...

August 18, 2026 | Tuesday | News
Pfizer and Valneva Lyme Disease Vaccine Application Validated by EMA

Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA)  announced that the European Medicines Agency (EMA) has validated the Mar...

August 18, 2026 | Tuesday | News
Thermo Fisher Scientific Completes $1.075 Billion Sale of Microbiology Business to Astorg

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has completed the sale of its microbiology business to ...

August 18, 2026 | Tuesday | News
QIAGEN Wins FDA Clearance for QIAstat-Dx Bloodstream Infection Panel

QIAstat-Dx BCID GPF Plus AMR Panel detects 20 pathogen targets and 10 antimicrobial resistance markers from positive blood cultures in about one hour...

August 12, 2026 | Wednesday | News
Philips and Exor Update Long-Term Agreement, Raising Potential Stake to 22%

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Exor N.V. announced that they have agreed to update their long-term relat...

August 12, 2026 | Wednesday | News
FDA Grants Accelerated Approval to Replimune’s Tudriqev for Advanced Melanoma

The U.S. Food and Drug Administration granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral t...

August 10, 2026 | Monday | News
Bavarian Nordic Expands MVA-BN Approval to Children Aged 2 and Older in EU

MVA-BN approval expanded to include children aged 2 to less than 12 years for protection against mpox, smallpox and disease caused by vaccinia virus A...

August 10, 2026 | Monday | News
GE HealthCare Launches Invenia ABUS Prime and ABUS StreamVue for Dense Breast Screening

Following the introduction of Invenia™ ABUS Prime at the Society of Breast Imaging Annual Symposium, the installation at BeSound in Los Angeles...

August 05, 2026 | Wednesday | News
Sanofi’s MenQuadfi Gains EU Approval for Infants From Six Weeks of Age

Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease Sanofi announced that the Europ...

August 05, 2026 | Wednesday | News
Building Confidence Beyond Compliance With Media Fills Designed for the Annex 1 Era

In the Annex 1 era, media fills must replicate the routine aseptic manufacturing process as closely as possible. This includes all critical manufacturing s...

August 03, 2026 | Monday | Expert Opinion

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close